AAM
EXAS

Advisors Asset Management’s Exact Sciences EXAS Stock Holding History

Advisors Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,685
Closed -$476K – 1476
2025
Q4 		$476K Sell
4,685
-15,356
-77% -$1.23M 0.01% 964
2025
Q3 		$1.1M Sell
20,041
-641
-3% -$32K 0.02% 758
2025
Q2 		$1.1M Sell
20,682
-9,480
-31% -$482K 0.02% 746
2025
Q1 		$1.31M Buy
30,162
+457
+2% +$23.1K 0.02% 683
2024
Q4 		$1.67M Buy
29,705
+1,055
+4% +$65.7K 0.03% 594
2024
Q3 		$1.95M Buy
28,650
+402
+1% +$22.7K 0.04% 564
2024
Q2 		$1.19M Sell
28,248
-8,531
-23% -$469K 0.02% 667
2024
Q1 		$2.54M Buy
36,779
+7,574
+26% +$479K 0.05% 475
2023
Q4 		$2.16M Buy
29,205
+7,702
+36% +$505K 0.04% 507
2023
Q3 		$1.47M Buy
21,503
+2,488
+13% +$211K 0.03% 591
2023
Q2 		$1.79M Buy
19,015
+5,186
+38% +$405K 0.04% 551
2023
Q1 		$938K Buy
13,829
+9,484
+218% +$610K 0.02% 778
2022
Q4 		$215K Sell
4,345
-2,546
-37% -$104K ﹤0.01% 1117
2022
Q3 		$224K Sell
6,891
-548
-7% -$22.6K ﹤0.01% 1117
2022
Q2 		$293K Sell
7,439
-8,384
-53% -$448K 0.01% 1068
2022
Q1 		$1.11M Buy
15,823
+35
+0.2% +$2.56K 0.02% 774
2021
Q4 		$1.23M Buy
15,788
+664
+4% +$58.6K 0.02% 773
2021
Q3 		$1.44M Sell
15,124
-2,061
-12% -$218K 0.02% 701
2021
Q2 		$2.14M Buy
17,185
+3,045
+22% +$363K 0.03% 580
2021
Q1 		$1.86M Buy
14,140
+3,505
+33% +$480K 0.03% 618
2020
Q4 		$1.41M Sell
10,635
-351
-3% -$42.4K 0.02% 680
2020
Q3 		$1.12M Sell
10,986
-4,189
-28% -$362K 0.02% 675
2020
Q2 		$1.32M Buy
15,175
+559
+4% +$44.7K 0.03% 608
2020
Q1 		$848K Sell
14,616
-2,802
-16% -$227K 0.02% 665
2019
Q4 		$1.61M Buy
17,418
+9,489
+120% +$834K 0.03% 607
2019
Q3 		$717K Buy
7,929
+3,269
+70% +$372K 0.01% 865
2019
Q2 		$550K Buy
4,660
+618
+15% +$62.3K 0.01% 979
2019
Q1 		$350K Buy
4,042
+404
+11% +$34.4K 0.01% 1180
2018
Q4 		$230K Buy
3,638
+2,616
+256% +$180K ﹤0.01% 1172
2018
Q3 		$81K Buy
+1,022
New +$66.6K ﹤0.01% 1383

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Advisors Asset Management's EXAS Position: Q1 2026 in Review

Advisors Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,685 shares — an estimated $476K sold.

Advisors Asset Management first reported a position in EXAS in Q3 2018 and held it in 30 quarters. The position peaked at $2.54M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Advisors Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Advisors Asset Management sold 4,685 Exact Sciences shares in Q1 2026, an estimated $476K.
  • Advisors Asset Management first reported a position in Exact Sciences in Q3 2018 and held it in 30 quarters.
  • Advisors Asset Management's Exact Sciences position peaked at $2.54M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.